Clinical Research Directory
Browse clinical research sites, groups, and studies.
Continuous Glucose Monitoring in Polycystic Ovarian Syndrome
Sponsor: The Cleveland Clinic
Summary
The purpose of this study is to learn more about blood sugar control in polycystic ovarian syndrome. The patient will be asked to wear a continuous glucose monitor (CGM) device that is applied to the arm with a sensor or filament that goes under the skin to measure your sugar levels. The patient will wear this at certain time points throughout the study. There will have a total of 2 blood draws (about 1 tsp. of blood) at screening and the 6-month visit, a measure of the patients body muscle and fat (body composition), and fill out a questionnaire at the end of the first 3 months and 6 months. Study participation in the research will last about 6 months.
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-12-24
Completion Date
2027-08-15
Last Updated
2026-02-06
Healthy Volunteers
No
Conditions
Interventions
Stelo glucose biosensor by Dexcom
Unblinded continuous glucose monitoring (CGM) system
Locations (1)
Cleveland Clinic
Cleveland, Ohio, United States